REQUEST A DEMO
Total
USD $0.00
Search more companies

Solispharm Sp. z o.o. (Poland)

Main Activities: Department Stores
Full name: Solispharm Sp. z o.o. Profile Updated: July 06, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Solispharm Sp. z o.o. is based in Poland, with the head office in Warsaw. The company operates in the Department Stores sector. The enterprise was incorporated on January 14, 2014. It currently has a total number of 51 - 100 (2016) employees. The company’s latest financial report indicates a net sales revenue increase of 62.43% in 2023. There was a total growth of 52.42% in Solispharm Sp. z o.o.’s total assets over the same period. Solispharm Sp. z o.o.’s net profit margin increased by 4.27% in 2023.

Headquarters
Ul. Starzynskiego 10
Warsaw; Mazowieckie; Postal Code: 03-459

Contact Details: Purchase the Solispharm Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Solispharm Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Solispharm Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Solispharm Sp. z o.o. report to view the information.
Incorporation Date:
January 14, 2014
Key Executives
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Solispharm Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
62.43%
Total operating revenue
62.07%
Operating profit (EBIT)
416.71%
EBITDA
398.91%
Net Profit (Loss) for the Period
337.71%
Total assets
52.42%
Total equity
119.76%
Operating Profit Margin (ROS)
5.99%
Net Profit Margin
4.27%
Return on Equity (ROE)
31.39%
Debt to Equity Ratio
0.73%
Quick Ratio
0.54%
Cash Ratio
0.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?